Quarterly report · Q1
4361.TEDINET S100QJKH
Period2022-12-01 → 2023-02-28
Filed2023-04-10
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 31
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥2.1bn | 2022-12-01 → 2023-02-28 | Cons. | Net sales |
| Revenue | ¥8.4bn | 2021-12-01 → 2022-11-30 | Cons. | Net sales (5-year summary) |
| Revenue | ¥1.9bn | 2021-12-01 → 2022-02-28 | Cons. | Net sales |
| Operating income | ¥47m | 2022-12-01 → 2023-02-28 | Cons. | Operating income |
| Operating income | ¥114m | 2021-12-01 → 2022-02-28 | Cons. | Operating income |
| Ordinary income | ¥46m | 2022-12-01 → 2023-02-28 | Cons. | Ordinary income |
| Ordinary income | ¥303m | 2021-12-01 → 2022-11-30 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥118m | 2021-12-01 → 2022-02-28 | Cons. | Ordinary income |
| Profit before tax | ¥46m | 2022-12-01 → 2023-02-28 | Cons. | Income before income taxes |
| Profit before tax | ¥118m | 2021-12-01 → 2022-02-28 | Cons. | Income before income taxes |
| Net income (owners) | ¥41m | 2022-12-01 → 2023-02-28 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥219m | 2021-12-01 → 2022-11-30 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥95m | 2021-12-01 → 2022-02-28 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥41m | 2022-12-01 → 2023-02-28 | Cons. | Profit loss |
| Net income | ¥95m | 2021-12-01 → 2022-02-28 | Cons. | Profit loss |
| Total assets | ¥8.2bn | at 2023-02-28 | Cons. | Assets |
| Total assets | ¥8.3bn | at 2022-11-30 | Cons. | Assets |
| Total assets | ¥7.8bn | at 2022-02-28 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥5.8bn | at 2023-02-28 | Cons. | Liabilities |
| Total liabilities | ¥5.9bn | at 2022-11-30 | Cons. | Liabilities |
| Net assets / equity | ¥2.4bn | at 2023-02-28 | Cons. | Net assets |
| Net assets / equity | ¥2.4bn | at 2022-11-30 | Cons. | Net assets |
| Net assets / equity | ¥2.3bn | at 2022-02-28 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥864m | at 2023-02-28 | Cons. | Cash and deposits |
| Cash and deposits | ¥911m | at 2022-11-30 | Cons. | Cash and deposits |
| EPS (basic) | ¥33.77 | 2022-12-01 → 2023-02-28 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥179.75 | 2021-12-01 → 2022-11-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥78.24 | 2021-12-01 → 2022-02-28 | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 29.1% | at 2023-02-28 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 29.0% | at 2022-11-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 29.4% | at 2022-02-28 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 18
| Segment | Item | Period | Value |
|---|---|---|---|
| jpcrp040300-q1r_E01006-000Pharmaceutical Productsreportable segment | revenue | 2022-12-01 → 2023-02-28 | ¥2.0bn |
| jpcrp040300-q1r_E01006-000Pharmaceutical Productsreportable segment | revenue external | 2022-12-01 → 2023-02-28 | ¥2.0bn |
| jpcrp040300-q1r_E01006-000Pharmaceutical Productsreportable segment | segment profit | 2022-12-01 → 2023-02-28 | ¥39m |
| jpcrp040300-q1r_E01006-000Real Estate Leasingreportable segment | revenue | 2022-12-01 → 2023-02-28 | ¥10m |
| jpcrp040300-q1r_E01006-000Real Estate Leasingreportable segment | revenue external | 2022-12-01 → 2023-02-28 | ¥10m |
| jpcrp040300-q1r_E01006-000Real Estate Leasingreportable segment | segment profit | 2022-12-01 → 2023-02-28 | ¥8m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-12-01 → 2023-02-28 | ¥2.1bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-12-01 → 2023-02-28 | ¥2.1bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-12-01 → 2023-02-28 | ¥47m |
| jpcrp040300-q1r_E01006-000Pharmaceutical Productsreportable segment | revenue | 2021-12-01 → 2022-02-28 | ¥1.9bn |
| jpcrp040300-q1r_E01006-000Pharmaceutical Productsreportable segment | revenue external | 2021-12-01 → 2022-02-28 | ¥1.9bn |
| jpcrp040300-q1r_E01006-000Pharmaceutical Productsreportable segment | segment profit | 2021-12-01 → 2022-02-28 | ¥106m |
| jpcrp040300-q1r_E01006-000Real Estate Leasingreportable segment | revenue | 2021-12-01 → 2022-02-28 | ¥9m |
| jpcrp040300-q1r_E01006-000Real Estate Leasingreportable segment | revenue external | 2021-12-01 → 2022-02-28 | ¥9m |
| jpcrp040300-q1r_E01006-000Real Estate Leasingreportable segment | segment profit | 2021-12-01 → 2022-02-28 | ¥8m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2021-12-01 → 2022-02-28 | ¥1.9bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2021-12-01 → 2022-02-28 | ¥1.9bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2021-12-01 → 2022-02-28 | ¥114m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 337
| Item | Context | Value | Unit |
|---|---|---|---|
| Company name in english cover page | FilingDateInstant | Kawaguchi Chemical Industry Co., Ltd | |
| Title and name of representative cover page | FilingDateInstant | Original text (Japanese)代表取締役社長 山 田 秀 行 | |
| Address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)東京都千代田区内神田２丁目８番４号(同所は登記上の本店所在地であり、実際の業務は、下記で行っております。) | |
| Telephone number address of registered headquarter cover page | FilingDateInstant | － | |
| Name of contact person address of registered headquarter cover page | FilingDateInstant | － | |
| Nearest place of contact cover page | FilingDateInstant | Original text (Japanese)本社事務所 埼玉県川口市領家４丁目６番42号 | |
| Telephone number nearest place of contact cover page | FilingDateInstant | 048(222)5171 | |
| Name of contact person nearest place of contact cover page | FilingDateInstant | Original text (Japanese)取締役経理部長 本 間 義 隆 | |
| Place for public inspection cover page (text) | FilingDateInstant | Text · Plus | |
| Edinet code | FilingDateInstant | E01006 | |
| Fund code | FilingDateInstant | － | |
| Security code | FilingDateInstant | 43610 | |
| Filer name in japanese | FilingDateInstant | Original text (Japanese)川口化学工業株式会社 | |
| Filer name in english | FilingDateInstant | Kawaguchi Chemical Industry Co., Ltd | |
| Fund name in japanese | FilingDateInstant | － | |
| Fund name in english | FilingDateInstant | － | |
| Cabinet office ordinance | FilingDateInstant | Original text (Japanese)企業内容等の開示に関する内閣府令 | |
| Document type | FilingDateInstant | Original text (Japanese)第四号の三様式 | |
| Accounting standards | FilingDateInstant | Japan GAAP | |
| Whether consolidated financial statements are prepared | FilingDateInstant | true | |
| Industry code when consolidated financial statements are prepared in accordance with industry specific regulations | FilingDateInstant | cte | |
| Industry code when financial statements are prepared in accordance with industry specific regulations | FilingDateInstant | － | |
| Current fiscal year start date | FilingDateInstant | 2022-12-01 | |
| Current period end date | FilingDateInstant | 2023-02-28 | |
| Type of current period | FilingDateInstant | Q1 | |
| Current fiscal year end date | FilingDateInstant | 2023-11-30 | |
| Previous fiscal year start date | FilingDateInstant | 2021-12-01 | |
| Comparative period end date | FilingDateInstant | 2022-02-28 | |
| Previous fiscal year end date | FilingDateInstant | 2022-11-30 | |
| Next fiscal year start date | FilingDateInstant | － | |
| End date of quarterly or semi annual period of next fiscal year | FilingDateInstant | － | |
| Amendment flag | FilingDateInstant | false | |
| Identification of document subject to amendment | FilingDateInstant | － | |
| Report amendment flag | FilingDateInstant | false | |
| Xbrl amendment flag | FilingDateInstant | false | |
| Business results of group (text) | FilingDateInstant | Text · Plus | |
| Description of business (text) | FilingDateInstant | Text · Plus | |
| Business risks (text) | FilingDateInstant | Text · Plus | |
| Management analysis of financial position operating results and cash flows (text) | FilingDateInstant | Text · Plus | |
| Critical contracts for operation (text) | FilingDateInstant | Text · Plus | |
| Total number of shares (text) | FilingDateInstant | Text · Plus | |
| Issued shares total number of shares etc (text) | FilingDateInstant | Text · Plus | |
| Class issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | Original text (Japanese)普通株式 | |
| Name of financial instruments exchange on which securities are listed or authorized financial instruments business association to which securities are registered | FilingDateInstant_OrdinaryShareMember | Original text (Japanese)東京証券取引所スタンダード市場 | |
| Description issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | Original text (Japanese)単元株式数は100株であります。 | |
| Details of employee share option program (text) | FilingDateInstant | Text · Plus | |
| Other information on share acquisition rights (text) | FilingDateInstant | Text · Plus | |
| Exercises etc of moving strike convertible bonds etc (text) | FilingDateInstant | Text · Plus | |
| Changes in number of issued shares stated capital etc (text) | FilingDateInstant | Text · Plus | |
| Major shareholders (text) | FilingDateInstant | Text · Plus |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |